Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Exchange Rate Effect: 2022-2024

Historic Exchange Rate Effect for Addex Therapeutics (ADXN) over the last 2 years, with Dec 2024 value amounting to -$75.3 billion.

  • Addex Therapeutics' Exchange Rate Effect fell 144.25% to -$75.3 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $201.3 billion, marking a year-over-year increase of 7024.25%. This contributed to the annual value of $113,309 for FY2024, which is 128.51% up from last year.
  • According to the latest figures from Q4 2024, Addex Therapeutics' Exchange Rate Effect is -$75.3 billion, which was down 198.90% from $76.1 billion recorded in Q3 2024.
  • Over the past 5 years, Addex Therapeutics' Exchange Rate Effect peaked at $170.1 billion during Q4 2023, and registered a low of -$197.6 billion during Q2 2023.
  • Moreover, its 3-year median value for Exchange Rate Effect was -$19,831 (2023), whereas its average is $366.2 million.
  • Within the past 5 years, the most significant YoY rise in Addex Therapeutics' Exchange Rate Effect was 72,829,481.37% (2023), while the steepest drop was 255,694,998.07% (2023).
  • Quarterly analysis of 3 years shows Addex Therapeutics' Exchange Rate Effect stood at -$233,588 in 2022, then skyrocketed by 72,829,481.37% to $170.1 billion in 2023, then slumped by 144.25% to -$75.3 billion in 2024.
  • Its Exchange Rate Effect was -$75.3 billion in Q4 2024, compared to $76.1 billion in Q3 2024 and $170.1 billion in Q4 2023.